ADMA Biologics ADMA Current State And Local Tax Expense Benefit
Current State And Local Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:CurrentStateAndLocalTaxExpenseBenefit.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's current state and local tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's current state and local tax expense benefit?
- ADMA Biologics (ADMA) reported current state and local tax expense benefit of $695K in Q4 2025.
- How has ADMA Biologics's current state and local tax expense benefit changed year-over-year?
- ADMA Biologics's current state and local tax expense benefit increased by 47.3% year-over-year, from $471.75K to $695K.
- What does current state and local tax expense benefit mean?
- The current tax expense or benefit incurred at the state and local government levels based on the company's operations in specific jurisdictions. This metric captures the regional tax impact on the company's bottom line. It helps investors evaluate the impact of geographic operational footprints on total tax liabilities.